Insider Transactions in Q1 2026 at Avidity Biosciences, Inc. (RNA)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 21
2026
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,929
-1.26%
|
$210,888
$72.45 P/Share
|
|
Jan 21
2026
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
1,758
-9.6%
|
$126,576
$72.45 P/Share
|
|
Jan 21
2026
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,542
-3.62%
|
$327,024
$72.45 P/Share
|
|
Jan 21
2026
|
W. Michael Flanagan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,534
-3.63%
|
$470,448
$72.45 P/Share
|
|
Jan 21
2026
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
14,387
-2.57%
|
$1,035,864
$72.45 P/Share
|
|
Jan 21
2026
|
Steven George Hughes Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,895
-6.94%
|
$352,440
$72.45 P/Share
|
|
Jan 07
2026
|
W. Michael Flanagan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,373
-2.52%
|
$170,856
$72.23 P/Share
|
|
Jan 07
2026
|
Steven George Hughes Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,373
-6.11%
|
$170,856
$72.23 P/Share
|
|
Jan 07
2026
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,974
-3.0%
|
$142,128
$72.23 P/Share
|
|
Jan 07
2026
|
John B Moriarty Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,374
-3.09%
|
$170,928
$72.23 P/Share
|
|
Jan 07
2026
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,965
-1.65%
|
$141,480
$72.23 P/Share
|
|
Jan 07
2026
|
Charles Calderaro Iii Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
3,727
-6.96%
|
$268,344
$72.23 P/Share
|
|
Jan 07
2026
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
8,576
-2.94%
|
$617,472
$72.23 P/Share
|